Contributor Page
Marks & Clerk
 
Email  |  Website  |  Articles
Contact Details
Tel: +44 20 7420000
Fax: +44 20 7836339
90 Long Acre
London
WC2E 9RA
UK
By Marianne Shepherd
The complex collection of microorganisms that colonise the human body and their genetic material (the human microbiome) is a rapidly developing area of research.
By Michael Shaw, Michael Barrett, Graham Burnett-Hall, Mathias Dormann, Chris Hemingway, Will Jensen, Will Nieuwenhuys, Thomas Prock, Mairi Rudkin, Upasana Patel
The 3rd quarter edition of our ReMarks newsletter is out
By Will Jensen
On 7 September, the EC published a position paper on intellectual property rights (including geographical indications)...
By Will Nieuwenhuys
Decision T 488/16 of the Boards of Appeal of the EPO has been published setting out the reasoning for the revocation of European patent number EP1169038 protecting the anti-cancer drug dasatinib (Sprycel®).
By Michael Barrett
On October 1st new amendments to the EU Trade Mark Regulation (EUTM Regulation), Implementing Regulation (EUTMIR) and Delegated Regulation (EUTMDR) come into effect across all member states.
By Thomas Prock
The European Patent Office has recently issued their guidance notes regarding obtaining, maintaining and managing Unitary Patents (UPs).
By Mairi Rudkin
Occasionally, patent infringement sees a truly landmark ruling that forces everyone to sit up and take notice – and one such ruling arrived last month.
By Graham Burnett-Hall
The UK government has published its draft EU Withdrawal Bill. Although frequently dubbed the "Great Repeal Bill" it does not in fact seek to repeal all the European law that currently has force in the UK.
By Will Jensen
On 7 September, the EC published a position paper on intellectual property rights (including geographical indications), setting out how the transition of the UK leaving the EU should take place ...
By Esther Ford
Intellectual Property (IP) is a barrier to market, not a licence to practice the idea. Realistically, it may not even guarantee commercial success…! However,
By Will Nieuwenhuys
When the Boards of Appeal of the European Patent Office revoked European patent number EP1169038 protecting the anti-cancer drug dasatinib (Sprycel®) back in February 2017...
By Graham Burnett-Hall
In the most important decision on patent infringement for over a decade, the UK Supreme Court has confirmed that UK law does provide for a doctrine of equivalents when determining the scope of patent protection.
By George Lucas
The Administrative Council has therefore amended Rules 27 and 28 EPC to effect this change.
By Michelle Hickey
A recent decision by the EPO's Boards of Appeals, T 1811/13, considers whether a lack of clarity in a claim can give rise to an allowable objection to insufficiency of disclosure.
By Jill Terris
Apparently, Captain Morgan has not found imitation to be the sincerest form of flattery and in a swashbuckling face-off, has forced Admiral Nelson to retreat from the liquor store shelves.